Title
Two-Stage Genotyping in Population-Based Association Studies
Speaker
Jaya Satagopan, Memorial Sloan-Kettering Cancer Center
Abstract
Gene-disease association studies based on case-control designs are commonly used to investigate candidate polymorphisms (markers) conferring disease risk. When evaluating a large number of markers, genotyping all the markers on all samples may be inefficient in resource utilization. An alternative two-stage approach is proposed here. In Stage 1 all the markers are evaluated on a fraction of the available subjects. The most promising markers are then evaluated on the remaining individuals in Stage 2. This approach can be cost-effective since markers unlikely to be associated with the disease can be eliminated in the first stage. Simulation studies show that, when the markers are independent as well as when they are correlated, the two-stage approach provides a substantial reduction in the total number of marker evaluations for a minimal loss of power. As a general guideline, the simulations over a wide range of parametric configurations indicate that evaluating all the markers on 50 percent of the samples in Stage 1 and evaluating the most promising 10 percent of the markers on the remaining subjects in Stage 2 provides near-optimal power while resulting in a 45 percent decrease in the total number of marker evaluations.
